Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including amyotrophic lateral sclerosis (ALS), post-bariatric hypoglycemia (PBH), and Wolfram syndrome
Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including amyotrophic lateral sclerosis (ALS), post-bariatric hypoglycemia (PBH), and Wolfram syndrome.